Óscar Briz

5.3k total citations · 1 hit paper
93 papers, 4.0k citations indexed

About

Óscar Briz is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Óscar Briz has authored 93 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Oncology, 29 papers in Surgery and 24 papers in Molecular Biology. Recurrent topics in Óscar Briz's work include Drug Transport and Resistance Mechanisms (65 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers) and Pediatric Hepatobiliary Diseases and Treatments (14 papers). Óscar Briz is often cited by papers focused on Drug Transport and Resistance Mechanisms (65 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers) and Pediatric Hepatobiliary Diseases and Treatments (14 papers). Óscar Briz collaborates with scholars based in Spain, Germany and Italy. Óscar Briz's co-authors include José J.G. Marı́n, María J. Perez, Rocı́o I.R. Macı́as, María A. Serrano, María J. Monte, Marta R. Romero, Elisa Lozano, Elisa Herráez, Jesús M. Bañales and Alba G. Blazquez and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Hepatology.

In The Last Decade

Óscar Briz

91 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bile-acid-induced cell injury and protection

2009 531 citations María J. Perez, Óscar Briz profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Óscar Briz Spain	37	2.1k	1.3k	1.0k	722	569	93	4.0k
Rocı́o I.R. Macı́as Spain	39	2.4k 1.1×	1.3k 1.0×	1.4k 1.3×	581 0.8×	653 1.1×	143	4.3k
María J. Monte Spain	36	2.1k 1.0×	1.1k 0.8×	1.2k 1.1×	814 1.1×	492 0.9×	115	3.8k
P. L. M. Jansen Netherlands	34	1.7k 0.8×	1.0k 0.8×	898 0.9×	764 1.1×	1.2k 2.1×	79	3.8k
María A. Serrano Spain	33	1.6k 0.8×	825 0.6×	797 0.8×	427 0.6×	744 1.3×	103	3.1k
Kousei Ito Japan	30	2.2k 1.1×	818 0.6×	693 0.7×	454 0.6×	1.1k 2.0×	119	3.5k
Siegfried Matern Germany	34	1.5k 0.7×	617 0.5×	1.1k 1.1×	1.2k 1.7×	272 0.5×	79	3.8k
Piter J. Bosma Netherlands	34	2.5k 1.2×	2.5k 1.9×	1.7k 1.7×	827 1.1×	2.6k 4.6×	91	6.4k
Coen C. Paulusma Netherlands	32	3.4k 1.6×	1.6k 1.3×	1.8k 1.8×	994 1.4×	1.3k 2.3×	68	5.2k
Curt Einarsson Sweden	30	1.6k 0.8×	870 0.7×	1.8k 1.8×	725 1.0×	299 0.5×	64	3.4k
Jan Snoeys Belgium	33	897 0.4×	1.2k 1.0×	529 0.5×	372 0.5×	451 0.8×	94	3.7k

Countries citing papers authored by Óscar Briz

Since Specialization

Citations

This map shows the geographic impact of Óscar Briz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Óscar Briz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Óscar Briz more than expected).

Fields of papers citing papers by Óscar Briz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Óscar Briz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Óscar Briz. The network helps show where Óscar Briz may publish in the future.

Co-authorship network of co-authors of Óscar Briz

This figure shows the co-authorship network connecting the top 25 collaborators of Óscar Briz. A scholar is included among the top collaborators of Óscar Briz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Óscar Briz. Óscar Briz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Forner, Alejandro, et al.. (2025). A three-gene resistome signature as a prognostic tool in hepatocellular carcinoma. Annals of Hepatology. 31(1). 102179–102179.

Cives-Losada, Candela, Óscar Briz, Elisa Lozano, et al.. (2025). A novel noninvasive test based on near-infrared fluorescent cholephilic probes for hepatobiliary secretory function assessment. Biomedicine & Pharmacotherapy. 187. 118074–118074. 1 indexed citations

Asensio, Maitane, Óscar Briz, Elisa Herráez, et al.. (2024). Sensitizing cholangiocarcinoma to chemotherapy by inhibition of the drug-export pump MRP3. Biomedicine & Pharmacotherapy. 180. 117533–117533.

Rodríguez‐Macías, Gabriela, Óscar Briz, Candela Cives-Losada, et al.. (2023). Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy. Cancers. 15(12). 3145–3145. 2 indexed citations

Romero, Marta R., et al.. (2023). Impact of tumor suppressor genes inactivation on the multidrug resistance phenotype of hepatocellular carcinoma cells. Biomedicine & Pharmacotherapy. 165. 115209–115209. 6 indexed citations

Herráez, Elisa, Ruba Al‐Abdulla, Óscar Briz, et al.. (2023). Role of organic cation transporter 3 (OCT3) in the response of hepatocellular carcinoma to tyrosine kinase inhibitors. Biochemical Pharmacology. 217. 115812–115812. 3 indexed citations

Marı́n, José J.G., María J. Monte, Rocı́o I.R. Macı́as, et al.. (2022). Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers. Cancers. 14(14). 3524–3524. 25 indexed citations

Hermanns, Heike M., Óscar Briz, José M. Herranz, et al.. (2022). Impact of Liver Inflammation on Bile Acid Side Chain Shortening and Amidation. Cells. 11(24). 3983–3983. 5 indexed citations

Marı́n, José J.G., et al.. (2020). Role of Genetic Variations in the Hepatic Handling of Drugs. International Journal of Molecular Sciences. 21(8). 2884–2884. 18 indexed citations

10.

Monte, María J., Óscar Briz, Raquel Luengo González, et al.. (2018). Interaction of glucocorticoids with FXR/FGF19/FGF21-mediated ileum-liver crosstalk. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(9). 2927–2937. 36 indexed citations

11.

Gonzalez‐Sanchez, Ester, María J. Perez, Óscar Briz, et al.. (2016). Protective role of biliverdin against bile acid-induced oxidative stress in liver cells. Free Radical Biology and Medicine. 97. 466–477. 38 indexed citations

12.

Blazquez, Alba G., Óscar Briz, Ester Gonzalez‐Sanchez, et al.. (2014). The effect of acetaminophen on the expression of BCRP in trophoblast cells impairs the placental barrier to bile acids during maternal cholestasis. Toxicology and Applied Pharmacology. 277(1). 77–85. 28 indexed citations

13.

Papacleovoulou, Georgia, Shadi Abu‐Hayyeh, Evanthia Nikolopoulou, et al.. (2013). Maternal cholestasis during pregnancy programs metabolic disease in offspring. Journal of Clinical Investigation. 123(7). 3172–3181. 101 indexed citations

14.

Vaquero, Javier, Óscar Briz, Elisa Herráez, Jordi Muntané, & José J.G. Marı́n. (2013). Activation of the nuclear receptor FXR enhances hepatocyte chemoprotection and liver tumor chemoresistance against genotoxic compounds. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1833(10). 2212–2219. 47 indexed citations

15.

Molina‐Jiménez, Francisca, Ignacio Benedicto, Viet Loan Dao Thi, et al.. (2012). Matrigel-embedded 3D culture of Huh-7 cells as a hepatocyte-like polarized system to study hepatitis C virus cycle. Virology. 425(1). 31–39. 76 indexed citations

16.

Serrano, María A., María J. Monte, Ester Gonzalez‐Sanchez, et al.. (2011). A homozygous nonsense mutation (c.214C→A) in the biliverdin reductase alpha gene ( BLVRA) results in accumulation of biliverdin during episodes of cholestasis. Journal of Medical Genetics. 48(4). 219–225. 39 indexed citations

17.

Marı́n, José J.G., Marta R. Romero, Alba G. Blazquez, et al.. (2009). Importance and Limitations of Chemotherapy Among the Available Treatments for Gastrointestinal Tumours. Anti-Cancer Agents in Medicinal Chemistry. 9(2). 162–184. 44 indexed citations

18.

Briz, Óscar, Doris Cassio, Alba G. Blazquez, et al.. (2007). Characterization of WIF-B9/R cells as an in vitro model with hepatocyte-like polarity and enhanced expression of canalicular ABC transporters involved in phase III of hepatic detoxification. Toxicology. 232(1-2). 24–36. 5 indexed citations

19.

Monte, María J., et al.. (2006). Expression of transporters potentially involved in the targeting of cytostatic bile acid derivatives to colon cancer and polyps. Biochemical Pharmacology. 72(6). 729–738. 64 indexed citations

20.

Briz, Óscar, Marta R. Romero, Rocı́o I.R. Macı́as, et al.. (2006). OATP8/1B3-mediated Cotransport of Bile Acids and Glutathione. Journal of Biological Chemistry. 281(41). 30326–30335. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact